High CD70 mRNA expression was also associated with shorter OS in a rituximab‐containing regimen‐treated DLBCL cohort (GSE117556)38 and TCGA DLBCL cohort (dbGaP Study Accession: phs00017839; figure generated by online OSDLBCL tool40) (Figure 6F,G). Here, CD70 is linked to diffuse large B-cell lymphoma.